1 unchanged sentence
following exhibits are filed as part of this report:
+Added: Amendment, effective November 1, 2024, to Amended and Restated Bylaws of Ensysce Biosciences, Inc.
+Added: (incorporated by reference to Exhibit 3.2(b) filed with the registrant’s Current Report on Form 8-K (File No.
+Added: 001-38306) on October 18, 2024).
Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
15 unchanged sentences
BIOSCIENCES, INC.
−Removed: August 14, 2024
+Added: November 12, 2024
David Humphrey
1 unchanged sentence
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.